SMOFLipid vs Clinoleic - randomised controlled trial

Phase 4

• Conditions: Parenteral nutrition associated cholestasis and liver disease; Late onset sepsis; Chronic lung disease; Patent ductus arteriosis; Premature birth- Intra-ventricular haemorrhage

• Registration Number: ACTRN12617000883314
• Lead Sponsor: epean Hospital NIC

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-06-16
• Last Update Posted: 4 July 2017

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified